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Integral membraneproteinspossessahydrophobic sequenceborderedbyhydrophilic
residues, a configuration that allows for anchorage in a lipid bilayer. Recently, an
alternative protein anchoring structure has been characterized which consists of a
complex glycosyl-phosphatidylinositol (GPI)' containing lipid (reviewed in refer-
ences 1 and 2). Thepurification ofa phospholipase C (PLC)specific for phosphatidyl
inositol(PI-PLC) from various bacterial strainshas greatly facilitated the identification
and characterization of these proteins.
PI-PLC was demonstrated tospecifically release the murine lymphocyte antigens
Thy-1, Qa, and T cell-activating protein (TAP). PI-PLC also mediates the release
ofdecay-accelerating factor, LFA-3, and one form ofthe neural cell adhesion mole-
cule(NCAM). Thus, GPI-anchored proteins are functionallydiverse and encompass
molecules reported to be involved in T cell activation (Thy-1 and TAP) (3, 4) and
adhesion (LFA-3, NCAM) (5, 6). It has been suggested that the GPI anchor may
confer increased lateral mobility to a protein, provide a mechanism for its selective
release from the cell surface, and/or provide a mechanism for cell activation (7-9).
Blast-1 is acell surface 40-45413 glycoprotein expressed on activated B cells, acti-
vated T cells, and monocytes (reference 10, and Staunton, D. E., and D. A. Thor-
ley-Lawson, manuscript in preparation). Analysis ofa cDNA encoding Blast-1 re-
veals amino acid sequence similarly to members of the Ig superfamily (11). The
sequence also revealed characteristics of GPI anchored proteins.
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Here we show that Blast-1 is anchored through GPI and extend the analysis of
homologous proteins to show that Blast-1 is the human homologue of OX45 and
most closely related to LFA-3. Last, we show that the gene for BLAST-I is localized
to chromosome lg21-q23.
Materials and Methods
Cells and Antibodies.
￿
The EBV immortalized B-lymphoblastic cell line (LCL) ER LCL
was established by in vitro EBV infection of peripheral blood B lymphocytes as previously
described (11). Peripheral blood T cells were isolated by Ficoll-Hypaque density centrifuga-
tion followed by 1-h adherence to plastic at 37°C in RPMI with 10% FCS. Nonadherent
cells were then rosetted with SRBC and the rosetting cells (T cells) were then isolated and
the sheep cells were lysed. This preparation was determined, by indirect immunofluorescence
with OKT3, to contain 96% T cells. T cells were then cultured at 106 cells/ml RPMI with
10% FCS and 1 hg/ml PHA (HA-16, Bourroughs-Wellcome Co., Greenville, NY) for 3 d
before PI-PLC treatment.
The generation of the anti-Blast-1 mAb 17136 was described previously (10). MOPC-11
is a negative control isotyped-matched mAb. W6/32 is an anti-MHC classI mAb. EBVCS-5
is an anti-Blast-2 (CD23) mAb (12). Anti-CD2 (TS2/18) was a kind gift of Dr. T. Springer
(Center for BloodResearch, Boston, MA). Indirect immunofluorescence and immunoprecipi-
tations were performed as previously described (10).
Phospholipase C Treatment of Cells.
￿
For analysis by indirect immunofluorescence, cultured
cells (106) were washed once with PLC buffer (RPMI with 2 mg/ml BSA, 10 mM Hepes pH
7.4, and 5 x 10-5M 2-ME). Cells were then resuspended in 1 ml of PLC buffer and in-
cubated at 37°C for 60 min with 1 IAM/min/ml (final activity) of PI-specific PLC (1) (a kind
gift from Dr. Martin Low), or no enyme. The cellswere then washed once with PLC buffer
followed by two washes with PBS containing 0.5% FCS and immediately incubated at 4°C
with antibodies for indirect immunofluorescence. For immunoprecipitation analysis, 2 x 10'
1251 surface-labeled cells were washed with PLC buffer and incubated in 1 ml of PLC buffer
at 37°C for 60 min with 1 uM/min/ml (final activity) of PI-specific PLC or no enzyme. The
cells were pelleted and the supernatant was centrifuged for 30 min at 13,000 g. The cells were
washed once in PLC buffer, twice in PBS, and then solubilized by the addition of 0.5 % NP-
40. Supernatant and solubilized cellswere precleared with formalin fixed Staphylococcus A
before immunoprecipitation and SDS-PAGE analysis, which were carried out as described
previously (11).
Hybrid Cell Lines and Chromosome Localization.
￿
Chromosomal location was analyzed as de-
scribed previously (13). All cell hybrids except series XIX were derived from fusions between
human cells and Chinese hamster V79/380-6 cells. The construction and characterization
ofthese hybrids have been summarized recently (13). Series XIX hybrids were derived from
fusions between human skin fibroblasts and rat Morris hepatoma 7777 cells. In some hybrids
of this series spontaneous translocation events have separated the short arm and long arm
of humanchromosome 1. The hybrid containing region lgter-q32 was derived from a human
donor with a t(1;2)(g32 ;q13) translocation (13a).
Genomic DNA was extracted from cultured cells as described. 10 mg of hybrid and pa-
rental control cell DNA were digested with restriction enzymes according to the manufac-
turers' instructions. A three- to fourfold excess ofenzyme was used and spermidine HCI (Sigma
Chemical Co., St. Louis, MO) was added to a final concentration of 4 mM. Hind III diges-
tions were carried out in TA buffer. DNA fragments were separated by electrophoresis in
0.8% agarose and transferred to Hybond-N (Amersham Corp., Arlington Heights, IL) as
described (13). Filters were pretreated and hybridized with gel-purified, 32p-labeled probe
as previously described, except that SDS (Bio-Rad Laboratories) was added to the pre- and
hybridization solutions to a final concentration of 1%.
In Situ Chromosomal Hybridization.
￿
Human metaphase cells were prepared from PHA-
stimulated peripheral blood lymphocytes. For autoradiographic localization, a radiolabeled
Blast-1 cDNA probe was prepared by nick translation of the entire plasmid with all four3H-labeled deoxynucleoside triphosphates to a specific activity of 1 .0 x 108 dpm/pg. In situ
hybridization was performed as described previously (14). Metaphase cellswere hybridized
at 2.0 and 4.0 ng of probe per Al of hybridization mixture. Autoradiographs were exposed
for 11 d. For chromosomal localization performed with biotinylated probes, a modification
of a previously described procedure (15) was used, details of which will be published else-
where (Lawrence,J. B., et al., manuscriptin preparation). Normal human lymphocytes were
hybridized with 2.5 pg/ml of two genomic clones (designated 2c and 5c, both of 16 kb) that
span the Blast-1 gene. The probes were labeled by nick translation with biotin-dUTP and
were detected with fluorescein-avidin. The nature of the analysis with the fluorescence tech-
nique differs from that of autoradiography; a statistical analysis is unnecessary because the
identical labeling of sister chromatids verifies the position of bona fide hybridization in a
single metaphase figure (15) and because the scatter ofsignal observed with autoradiography
is eliminated. Hence, careful analysis of a few well-banded metaphase chromosomes after
hybridization provides a comparatively precise placement of the gene. The position of hy-
bridization signals was aligned with G bands on normal human metaphase chromosomes
which had been GiemsaJtrypsin banded and photographed before hybridization.
Results
Linkage of Blast-1 to N..
￿
The translated sequence of a Blast-1 cDNA predicts a
19 amino acid hydrophobic COOH terminus devoid of charged residues that might
serve as a cytoplasmic anchor. This is a characteristic of proteins that have been
found anchored to the plasma membrane by processing which links the COOH ter-
minusto GPI. Therefore, the possible linkage ofBlast-1 to GPI was examined. Treat-
ment ofER-LCL with PI-PLC resulted in a marked decrease in binding ofan anti-
Blast-1 mAb (17136) as determined by indirect immunofluorescence (Fig. 1 A). This
decrease was specific for Blast-1 and was not observed with CD23 (Fig. 1 B), which
is known to possess a cytoplasmic tail. Interestingly, -60% of Blast-1 on ER LCL
was resistant to PI-PLC digestion (Fig. 1 A), even in the presence of increasingly
higher concentrations of enzyme (data not presented). By contrast all of the Blast-1
detected by immunofluorescence on PHA-activated T cells could be removed by diges-
tion with PI-PLC (Fig. 1 C). This decrease was again shown to be specific since
in this case the non-PI-linked CD2 marker was unaffected (Fig. 1 D). Digestion
with PLC lacking PI specificity did not effect Blast-1 expression (not shown).
To directly demonstrate the PI-PLC sensitivity of Blast-1, immunoprecipitations
were performed from 1251 surface-labeled ERLCL and PHA-activated T cells and
their cell supernatants after PI-PLC digestion or mock digestion. Whereas Blast-1
was only detected on the membranes of mock-digested ER-LCL, it was found in
FIGURE 1.
￿
Release of Blast-1 from B
and Tlymphocyteswith PI-PLC. The
B-lymphoblastoid cell line ERLCL(A
and B) or PHA-activatedTcells(Cand
D) were treated(--) ornottreated(---)
with PI-PLC before indirect immuno-
fluorescence usinganti-Blast-1 (A and
C). Anti-CD23 (B) and CD-2 (D)
mAbs were used as specificity controls
forthedigestion. Theweakest fluores-
cent profile represents staining with
Plumommm mNu.ny-W
￿
fluorescein-labeled goat anti-mouse
IgG alone.
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both the membrane and supernatants of PI-PLC-digested cells (Fig. 2, left) . Simi-
larly, Blast-1 was precipitated from thesupernatant ofPI-PLC-digested PHA-activated
T lymphocytes (Fig. 2, right) . Unlike the B cells, and consistent with the fluorescence
analysis, residual Blast-1 was not detected on membranes of activated T cells after
PI-PLC digestion . Thus, digestionwithPI-PLC results in the specific release ofBlast-1
rather than the nonspecific destruction ofthe epitope recognized by 17D6 . As a con-
trol for the specificity of the enzyme, HLA-class I that possesses a cytoplasmic tail
was shown not to be released from ER LCL cells by PI-PLC (Fig. 2) . These experi-
ments indicate that there exists at least one form of Blast-1 anchored to the surface
ofT and B cellsby linkage to GPI andthat, in contrast to B lymphoblasts, themajority
of Blast-1 on PHA-activated T cells appeared to be sensitive to PI-PLC digestion .
Sequence and Structural Similarities Between Blast-1, 0X45 andLFA-3 .
￿
Blast-1 was pre-
viously demonstrated to possess amino acid sequence homology with members of
the Ig superfamily (11) . A direct comparison was therefore made with proteins that
recently have been demonstrated to possess a PI anchor andIg-like domains . Using
protein alignment programs, no significant homology was observed between Blast-1
and NCAM, decay-accelerating factor, Qa, TAP, and Thy-1 (data not presented) .
The alignment, however, over the entire length of Blast-1 (217 residues)and OX45
(218 residues) yields 50% identity (Fig . 3) . Considering conservative amino acid sub-
stitutions (16), the overall homology becomes 81% . There is 45 and 54% identity
within the first and second Ig-like domains (DI and D2), respectively. Their hydro-
phobic COON-terminal sequences are 58% identical . This degree ofhomology is
consistent for human and rodent protein homologues .
The alignment over the entire length of Blast-1 and LFA-3 (210 residues) yields
25% identity (Fig . 3) . There is 31% identity between the Dl of Blast-1 and LFA-3 .
Considering conservative amino acid substitutions, the similarly between the two
Dl sequences becomes 63% . The percentage of identical residues that aligned in
D2 was considerably less (18%) . The most NH2-terminal N-linked glycosylation sites
in Blast-1, LFA-3, and OX45 were also aligned . It can also be observed that the same
conserved regions of strong homology in D1 between Blast-1 and OX-45 also occur
in LFA-3 (Fig. 3 A) .
FIGURE 2 .
￿
Blast-1 (B) and HLA
class I (H) were immunoprecipi-
tated from 1211-labeled ERLCL
(left panes and day 3 PHA-stimu-
latedT cellblasts (right panel) . Pro-
teins were immunoprecipitated
from both membranes(* and cul-
ture supernatants (S) after PI-PLC
treatment (+) or no PI-PLC treat-
ment (-) .r e u
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Secondary structures were predicted using the criteria ofChou and Fasman (17) .
The majority of a strand predictions for Blast-1 and LFA-3 are similarly located
(Fig . 3 A) . Alignment of the hydrophobicity profiles (18) of Blast-1 and LFA-3 also
suggests an overall similar organization (Fig . 3 B) .
The alignment between Blast-1 and LFA-3 also includes three cysteines in their
second domains (Fig . 3) . Theexistenceofadisulfide-bonded seconddomain in Blast-1
and LFA-3 is supported here by their decreased mobility under reducing conditions
relative to nonreducing conditions . "'I-labeled Blast-1 immunoprecipitated from
ER-LCL and LFA-3 purified from the B-lymphoblastoid cell lineJY were first digested
with N-glycosidase F to increase the resolution on SDS-PAGE . In Fig . 4A the prod-
ucts of theN-glycosidase digestion of Blast-1 corresponding to zero and oneN-linked
oligosaccharide forms migrated more slowly underreducing conditions, demonstrating
the presence of a disulfide-bonded domain in Blast-1 . A similar reduction in mo-
bility was observed in deglycosylated LFA-3 when subjected to SDS-PAGE under
reducing conditions (Fig. 4 B) .
Thus, Blast-1 isahomologue ofOX45 and possesses several similarities to LFA-3,
including polypeptide length, amino acid sequence, predicted secondary structure,
hydrophobicity, and a disulfide-bonded second domain .
Chromosome Localization of the Gene for Blast-1.
￿
It has been recently been shown
(19) that the genes for two members of the Ig superfamily, LFA-3 and CD2, map
to the same band ofchromosome 1. To demonstrate ifthe gene forBlast-1 waslinked
to any member of the superfamily, its chromosomal localization was determined .
This was initially done by Southern blot analysis ofDNA from 15 Chinese hamster
x human hybrid cell lines (Materials and Methods) with the Blast-1 cDNA probe .
Fragments of 3 .1, 2.5, 1.3, and 0.95 kb were detected by this probe on Southern
blots of Bgl II-digested human DNA (Fig . 5 A, lane 1) and in all hybrids which
had retainedhuman chromosome 1 (Fig. 5 A, lanes 5, 8, 10, and12) . Allother human
chromosomes were ruled out as possible sites of any one of these hybridizing frag-
mentsby three or more discordant hybrids (Table 1) . No significant crosshybridiza-
tion was seen with Chinese hamster DNA (Fig. 5 A) .
FIGURE 4 .
￿
(A) Immunoprecipitation
of Blast-1 and LFA-3 from ER-LCL
under reducing (R) and nonreducing
(NR) conditions . Blast-1 wasimmuno-
precipitated and digested with N-gly-
cosidase (NR andR) or not treated (G-
glycosylated) before SDS-PAGE on a
10% polyacrylamide gel . 1 and0 indi-
cate one andno N-linked oligosaccha-
ride forms of Blast-1 . (B) LFA-3
purified from the lymphoblastoid cell
lineJY was subjectedto SDS-PAGE as
described above for Blast-1 . An ex-
pected reduction in N-glycosidase (N-
gly) mobility under reducing conditions
is evident . Molecular mass (kilodal-
tons) shown to right of each panel .STAUNTON ET AL .
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FIGURE 5 .
￿
Chromosomal localization ofthe Blast-1 gene . (A) Hybridization of "P-labeled Blast-1
cDNA probe to aSouthern blot of Bg1 VII-digested DNA from human x Chinese hamster hy-
brid cell lines and controls . (Lane 1) HumanDNA; (lanes 2-12) human x Chinese hamster hy-
brid cell DNAs . The four human bands were always present together, as was evident in lane
8on a longer exposure . (B) Analysis ofthree additional hybrids containing portions of chromo-
some 1 . Theheavy vertical bars indicate the regions present in the three hybrids . + and - sign
at the top indicate absence and presence ofhuman Blast-1 restriction fragments in these hybrids .
The bracket indicates the localization of the Blast-1 sequence.
To define the regional location of Blast-1 sequences on chromosome 1, we ana-
lyzed three additional hybrids containing portions ofhuman chromosome 1 in the
absenceofthe intact chromosome . The results oftheseanalyses arepresented graphi-
cally in Fig. 5 B. The heavy vertical bars indicate the portions of chromosome 1
present in three independently derivedhybrids. No Blast-1 sequences were detected
when only the short_arm of chromosome 1 (region A) was present, while all four
restriction fragments were detected in hybrids that had retained either the entire
long arm (region B) or the short arm and a portion of the long arm (region C) .
The shortest region of overlap in the two positive hybrids was the proximal long
arm of chromosome 1 (region cen-q32), and we assigned Blast-1 to this region .
To further sublocalize the Blast-1 gene on chromosome 1, we hybridized theBlast-1
cDNA probe to normal metaphase chromosomes . This resulted in specific labeling
only of chromosome 1. Of 100 metaphase cells examined, 30 (30%) were labeled
on regionq2 ofone or both chromosome 1 homologues . The distribution oflabeled
sites on this chromosome is illustrated in Fig. 6; of 204 labeled sites observed, 64
(31.4%) were located on this chromosome . These siteswere clustered at bands q21-q24,
and this cluster represented 19.1% (39/204) of all labeled sites (cumulative proba-
bility for the Poisson distribution is <0.0005) . The largest number of grains was ob-
served at lg21-q23 . All hybridizations were repeated three times and gave similar
results . Thus, the Blast-1 gene was localized to chromosome 1, at bands q21-q23 .1094
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FIGURE 6 .
￿
(A) Autoradiographic distribution ofla-
beled sites on chromosome 1 in 100 normal human
metaphase cells from PHA-stimulated peripheral
blood lymphocytes that were hybridized with the
Blast-1 cDNA probe . The labeled sites observed in
this hybridization were clustered at lg21-q24 ; the
largest clusterofgrains was located at lg21-q23 . (B)
Fluorescence localization ofthe Blast-1 gene after hy-
bridization of biotinylated genomic Blast-1 probes
to G-banded cytogenetic preparations of PHA-
stimulated normal humanlymphocytes . Because of
the high resolution and signal-to-noise ratios of this
technique, label was observed at essentially thesame
localization in four independent measures . Within
the limits of resolution of this technique the place-
ment of the gene is narrowed to a region corre-
sponding to 1821.3-1822 as indicated .
Recently, ahigher resolution method of gene localization has been developed (15)
usingbiotinylatedDNA probes detected with fluoresceinated avidin . Use ofthis tech-
nique provides more precise localization, since the resolution of fluorescence (0 .1
j,m) is 10-20-fold greater than that of tritium autoradiography, due to the scatter
of radioactive disintegrations. Usingtwo biotinylated genomicclones for Blast-1 DNA,
collectively representing -32 kb of DNA, in situ hybridization was performed and
Blast-1 gene localization was assessed after fluorescein-avidin detection . As indicated
in Fig . 6 B, the signals fell on or near the border of 1821 and 1822 . No signal was
detected on anyother region ofchromosome 1 oronany other chromosome . Signals
on each chromosome were independently assessed by two investigators with the same
results . This result agrees well with the above results from autoradiographic anal-
ysis, whichwere derived entirely independently . Further, using this nonisotopic ap-
proach, label was notobserved over 1823 or the upper two-thirds of 1821, narrowing
the most likely placement to within 1821 and 1822 .
Discussion
The recent isolation and sequence analysis of acDNA encoding Blast-1 revealed
that, except for a single hydrophobic COOH-terminal sequence, it is a predomi-
nantly hydrophilic polypeptide (11) . The hydrophobic COOH terminus could act
as a membrane anchor, although it lacks charged residues that might function as
acytoplasmic tail andcontains aproline residue thatwould disruptan a-helix struc-
ture that could traverse the plasma membrane . These characteristics are common
to a group of proteins that are anchored to the membrane by linkage to a lipid con-
taining glycosyl-phosphatidylinositol (1, 2) . The prediction that Blast-1 may be an-
chored to the membrane in a similar fashion wasconfirmed by the PI-PLC-mediated
release of Blast-1 from the cell surface .
The PI-PLC-mediated release of Blast-1 from B cells was incomplete . This sug-
gests that a fraction ofBlast-1 on B cells either lacks a GPI anchor, possessesamodified
GPI anchor that is not a substrate of the specific PI-PLC used, or is associated with
another surface molecule that inhibits PI-PLC digestion . The reason for a PI-PLC-
resistant form of Blast-1 on B-LCL remains to be determined . In contrast, the PI-1096
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PLC-mediated release ofBlast-1 from PHA-stimulated Tcells is relatively complete,
suggesting that one GPI-anchored form of Blast-1 may exist on these cells.
The predicted site of GPI attachment to serine at position 195 (Fig. 3) is based
on that determined for MRC OX45 (20). Attachment to serine has been observed
and predicted for a number of proteins. In these proteins the attachment site does
not appear to include residues with large side chains and occurs approximately 5-10
residues from the carboxyl terminal hydrophobic sequence (2). The predicted site
of GPI attachment in Blast-1 is within six residues of that predicted for LFA-3 (2)
in the alignment depicted in Fig. 3 A.
The nature of Blast-1's membrane linkage might be expected to play a role in its
function. It hasbeen suggested that a GPI anchor may confer greater mobility, pro-
vide a specific mechanism of membrane release, and/or result in protein kinase C
activation via release of diacylglycerol . Further investigation is required to deter-
mine such a function(s) for Blast-1.
Previously Blast-1 was shownto possess amino acid sequence homology to members
of the Ig superfamily including CD4 (11). In an attempt to gain functional insights
into Blast-1, acomparisionwasmade to Ig-related, GPI-anchored proteins forwhich
amino acid sequence has recently become available. No striking sequence similari-
ties were observed except to OX45 (20) and LFA-3 (21, 22). The degree ofhomology
between Blast-1 and OX45 suggests that they are homologues. The similar tissue
distribution ofOX45 (23) and Blast-1 (Staunton, D. E., and D. A. Thorley-Lawson,
manuscript in preparation) is consistant with this notion. The firstdomain of Blast-1
and LFA-3 are clearly related (Fig. 3). A similar degree of homology between dis-
tinct GPI-anchored proteins has not been previously observed. It is also not sur-
prising, given the homology between LFA-3 and CD2 (22), that Blast-1 is also ho-
mologous and structurally similarto CD2 (Fig. 3B). Thedegree ofhomology between
Blast-1 and CD-2 is equivalent to that between CD2 and LFA-3. Blast-1, LFA-3,
and OX45 also have similarsize polypeptide lengths (217, 207, and219, respectively),
a similar number of N-linked glycosylation sites (5, 6, and 5, respectively), similar
secondary structure predictions and hydrophobicity profiles, and they all lack a
disulfide bond in their NH2-terminal domain. On this basis, Blast-1 has recently
been placed in a subfamily of the Ig superfamily, along with OX45, LFA-3, CD2,
carcinoembryonic antigen (CEA), and noncrossreactive antigen (NCA) (24).
We have localized the gene for Blast-1 to chromosome 1 between bands q21-q23
using twocompletely independent methods: traditional autoradiographyand a new
fluorescence-based technique usingbiotinylated probes. Thelatter techniqueallows
for more precise mapping than the traditional approach due to the high resolution
of fluorescence and lack of signal scatter associated with autoradiography. This
represents the first report of mapping of an unknown gene by these complementary
techniques. Also mapping to chromosome 1 are other members of the Ig superfa-
mily, including LFA-3 and CD2 (19) at 1p13, the CD1 cluster at lg22-q23 (25), and
the IgG Fc receptor at 1832 (Ravetch,J., personal communication). The gene local-
ization for Blast-1 is indistinguishable from that of the CD1 cluster, and thus they
may be linked. However, a more detailed molecular analysis will need to be per-
formed to ascertain the precise distance between these two genes. This raises the
possibility that therecouldbe clusters ofimmunoglobulin superfamily members lo-
cated in several regions of chromosome 1, since it has recently been observed thatSTAUNTON ET AL.
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the LFA-3 and CD2 genes are located on a single 130 kb piece of genomic DNA
(reference 19, and Crumpton, M. J., personal communication). This is of interest
since both CD2 and Blast-1 are closely related to LFA-3 in their extracellular do-
mains. This implies that related genes have arisen from a common precursor, both
close to and distant from each other on chromosome 1. Alternatively, these genes
mayhave converged due to having relatedfunctions, implying that Blast-1 mayhave
a role in cell adhesion.
Blast-1, 0X45, LFA-3, andCD2 are thus evolutionarily and perhaps functionally
related. OX45 has been demonstrated to enhance macrophage-mediated suppres-
sion of an allogenic MLR and a secondary T cell response to soluble antigen (26).
The failure of 17D6 to inhibit MLR (data not presented) may be due to its poor
affinity and the fact that its epitope occurs in the COOH half of Blast-1 (11). LFA-3
is a ligand forCD2 and functions in Tc adhesion to target cells and thymocyte adhe-
sion to thymic epithelial cells (5). Blast-1 may function similarly in cell-cellinterac-
tion. It could conceivably function as an alternative ligand for CD2. Interaction
between CD2 and an additional ligand other than LFA-3 has been proposed (27).
We are currently re-examining thefunction of Blast-1 usingBlast-l-expressing trans-
fectants and by generating additional anti-Blast-1 mAbs.
Summary
Blast-1 is a human activation-associated glycoprotein expressed on the surface of
leukocytes. Analysis of a translated sequence from a Blast-1 cDNA reveals a single
hydrophobic sequence which could traverse the plasma membrane, but is devoid
ofcharged residues that might represent acytoplasmic tail. Consistent with this char-
acteristic, Blast-1 is demonstrated here to be anchored to the cell surface through
a glycosyl-phosphatidylinositol (GPI)-containing lipid. Comparison of Blast-1 to other
GPI-anchored membrane proteins revealed a striking primary andsecondarystruc-
ture similarity with MRC OX45 and the lymphocyte function antigen LFA-3. The
degree of overall amino acid sequence homology reveals that OX45 is a rat homo-
logue of Blast-1. The greatest homology to LFA-3 occurs between their NH2-
terminal Ig-like domains. Evidence is presented that demonstrates that Blast-1 and
LFA-3 possess adisulfide-bonded second domain. Thesecommon characteristicsdem-
onstrate a structural and evolutionary relationship between Blast-1, 0X45, LFA-3,
and CD2, whichin turn suggests afunctional role for Blast-1 in cell-cellinteractions
in the immune response. The gene for Blast-1 has been localized to chromosome
1 q21-q23, indistinguishable from the CD1 cluster of Ig superfamily genes, raising
the possibility that they may be linked.
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